Loading the latest PSX data…
Loading the latest PSX data…
Macter International LimitedShariah-compliant
−0.83 (−1.58%) today
Market closed, last update Nov 17, 2026 5:39 AMThe Macter International share price was Rs 51.68 (−1.58%) at the last PSX update (Nov 17, 2026 5:39 AM). MACTER is a pharmaceuticals stock with a market value of Rs 11.8bn.
Last session's range16 Nov 2026
50.5019% up the range56.80
52-week range
44.0026% up the range73.00
Price limits (circuit breakers)
47.2642% up the range57.76
MACTER ranks better than 51% of the 309 liquid PSX stocks we score. Each factor is a 0-100 rank (value is ranked half within pharmaceuticals). Education only, not a buy or sell signal.
−6.7% over 6M(KSE-100 +4.9%)
Daily bars from PSX's end-of-day market summary. Prices before a bonus issue, right issue or split are adjusted so the chart stays continuous; cash dividends are not taken out.
Full-screen MACTER chart with levelsDownload MACTER price history (CSV)Compare MACTER with GLAXO
From daily closes to 2026-11-16. A description of the trend, not a forecast.
Trend reading
Mixed
Down3 up · 2 down signalsUp
| S2 | S1 | Pivot | R1 | R2 |
|---|---|---|---|---|
| 46.69 | 49.19 | 52.99 | 55.49 | 59.29 |
−50.6% over 5 years
Monthly closing prices from the PSX Data Portal, since 2017. Earlier prices are adjusted for bonus shares and splits (about 10% bonus or ex-dividend fall, 2022-12) so the line shows the value of one original share.
| Announced | Period | Payout | Profit after tax | EPS (Rs) | Books close |
|---|---|---|---|---|---|
| 22 Oct 15:36 | 1st quarter to 30 Sept | None | – | 2.10 | – |
| 22 Oct 15:35 | 1st quarter to 30 Sept | None | Rs 99.1m | 2.16 | – |
| 23 Sept 15:39 | Full year to 30 Jun | None | – | 14.83 | – |
| 23 Sept 15:36 | Full year to 30 Jun | None | Rs 698.3m | 15.24 | 21 Oct – 28 Oct |
| 28 Apr 09:37 | 9 months to 31 Mar | None | – | 11.50 | – |
| 28 Apr 09:37 | 9 months to 31 Mar | None | Rs 518.9m | 11.33 | – |
| Measure | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Sales growth | +18.3% | +31.6% | +12.8% | – |
| Profit growth | −5.3% | +72.7% | +8.7% | – |
| EPS growth | −5.3% | +72.7% | +8.6% | – |
| Net margin | 6.0% | 7.4% | 5.7% | 5.9% |
| Measure | Q1 2027 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Sales growth | +11.7% | – | – | – |
| Profit growth | −36.6% | – | – | – |
| EPS growth | −36.7% | – | – | – |
| Net margin | 3.2% | 3.3% | 8.1% | 5.6% |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Sales | Rs 11.7bn | Rs 9.9bn | Rs 7.5bn | Rs 6.7bn |
| Profit after tax | Rs 698m | Rs 738m | Rs 427m | Rs 393m |
| Earnings per share (Rs) | 15.24 | 16.10 | 9.32 | 8.58 |
| Line item | Q1 2027 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Sales | Rs 3.1bn | Rs 2.8bn | Rs 3.3bn | Rs 2.8bn |
| Profit after tax | Rs 99m | Rs 92m | Rs 271m | Rs 156m |
| Earnings per share (Rs) | 2.16 | 2.00 | 5.91 | 3.41 |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross margin | 48.3% | 45.0% | 42.2% | 41.7% |
| Net margin | 6.0% | 7.4% | 5.7% | 5.9% |
| EPS growth | -5.3% | 72.8% | 8.6% | 19.3% |
| PEG | -3.37 | 0.43 | 1.17 | 0.59 |
Rupee amounts from PSX filings (thousands converted to Rs m/bn). Data by Capital Stake via the PSX Data Portal; standardised, so it can differ from the annual report. Latest quarter (Q1 2027) EPS fell 36.7% from the same quarter a year earlier.
| Measure | MACTER | Sector median | Reading |
|---|---|---|---|
| P/E | 3.7 | 12.4 | Cheaper than peers |
| Dividend yield | – | 5.1% | – |
| Net margin | 6.0% | 9.4% | Below peers |
| EPS growth | −5.3% | +34.5% | Below peers |
| 1-year return | −28.2% | −12.0% | Below peers |
Sector P/E check. At the sector's median P/E of 12.4, last year's EPS of Rs 15.24 would price MACTER at about Rs 188.33 (+264% from today). A rough yardstick only: sectors hold very different businesses, and the market prices future profits, not last year's.
Estimate a fair value for MACTER (Graham, Lynch, DCF)MACTER pivot levels
Ratios as published on the PSX Data Portal (standardised by Capital Stake), latest financial year on the right.
Work out your MACTER dividend income after tax
PSX quotes payouts as a percentage of face value; cash per share assumes the usual Rs 10 face value. You get the dividend if you own the shares before the books close.
Market value
12th of 18
Rs 11.8bn
P/E (cheapest first)
1st of 13
3.7
1-year return
15th of 15
-28.2%
EPS growth
13th of 15
-5.3%
Net margin
11th of 16
6.0%
danioPSX score
7th of 13
51/100
| GLAXOGlaxoSmithKline Pakistan Limited | Rs 108.1bn | +0.96% | 9.8 | 6.1% | −13.9% | 89 |
| ABOTAbbott Laboratories (Pakistan) Limited | Rs 98.3bn | +0.39% | 10.6 | 4.4% | −8.1% | 80 |
| HALEONHaleon Pakistan Limited | Rs 80.7bn | −1.06% | 12.4 | 3.6% | −15.7% | 65 |
| HINOONHighnoon Laboratories Limited | Rs 50.7bn | −0.30% | 12.3 | 5.4% | −15.4% | 78 |
| SEARLThe Searle Company Limited | Rs 46.7bn | +0.27% | 12.0 | – | −22.9% | 53 |
| AGPAGP Limited | Rs 43.5bn | −0.59% | 24.3 | 5.1% | −16.6% | 50 |
| HPLHoechst Pakistan Limited | Rs 38.5bn | +0.14% | 11.0 | 6.9% | −2.5% | – |
| FEROZFerozsons Laboratories Limited | Rs 15.9bn | +0.67% | 23.1 | 1.6% | −8.8% | 39 |
| CPHLCiti Pharma Ltd. | Rs 14.5bn | +0.19% | 17.8 | – | −21.6% | 31 |
| GSKCHGlaxoSmithKline Consumer Healthcare | Rs 14.1bn | −3.13% | – | – | – | – |
| BFBIOBF Biosciences Limited | Rs 12.0bn | +0.64% | 18.3 | – | −10.1% | 44 |
| MACTERThis stock · Macter International Limited | Rs 11.8bn | −1.58% | 3.7 | – | −28.2% | 51 |
| SAPLSanofi-Aventis Pakistan Limited | Rs 8.4bn | 0.00% | – | – | – | – |
| OTSUOtsuka Pakistan Limited | Rs 5.7bn | +5.78% | 11.6 | – | +35.9% | 65 |
| LIVENLiven Pharma Limited | Rs 4.9bn | +10.00% | – | – | −9.0% | 11 |
Swipe the table sideways for more columns.
| Date | Who | Trade | Shares | Price | Value | Holding after | Notice |
|---|---|---|---|---|---|---|---|
| 6 Aug 26 | Asif MisbahExecutive Director | GIFT ouTThrough CDC | 150,000 | 10.00 | – | 14,136,55830.86% | Notice |
| 7 Aug 26 | Swaleh Misbah KhanExecutive Director | G 6 IFT INThrough CDC | 150,000 | 0.00 | – | 14,126,68630.84% | Notice |
| 4 Aug 26 | Swaleh Misbah KhanExecutive Director | GIFT ouTThrough CDC | 775,000 | 10.00 | – | 138,976,68630.51% | Notice |
Read automatically (OCR) from the disclosure images companies file with PSX under Regulation 5.6.1(d). A digit can be misread, so check the original notice before relying on a figure. Value = shares × price. Not investment advice. All PSX insider trades
Macter International Limited was incorporated in Pakistan in 1992 as a private limited company and was converted into a public limited company in 2011. The principal activity of the company is to manufacture and market pharmaceutical products.
Where the price sits in its 52-week range
Low 50.500% of the way upHigh 365.00
Data: PSX Data Portal (Nov 17, 2026 5:39 AM); company data refreshed 17 Nov; daily bars from PSX market summaries; five-year record from danioPSX research. Logos are trademarks of their owners. Not a recommendation to buy or sell MACTER. Official PSX page for MACTER